DTP Preclinical Services
The Developmental Therapeutics Program (DTP) offers drug discovery and development resources and services to the research community. Visit https://dtp.cancer.gov/ for more information.
Services specifically offered by DTP include:
DTP drug discovery and pre-clinic development services
Discovery services (NCI60 screening etc.) and pre-clinical support (pharmacology, toxicology and cGMP production etc.).
Synthetic compounds, natural products, biological samples and standards.
DTP databases and searching/analysis tools
Bulk DTP chemical and biological data for searching and download, COMPARE analysis.
DTP grant programs
Grants for preclinical anti-cancer drug discovery and treatment, including small molecules, natural products and biological agents.
Advice on development of small molecules, biologics, and imaging products intended for cancer patients.
Access to discrete drug development studies for NCI/DCTD grantees.
DTP also provides services to the NCI Experimental Therapeutics (NExT) program, a distinct program which provides resources for projects focused on developing therapies for unmet needs that are not adequately addressed by the private sector. For more information about how to apply to the NExT program, click here.